WBIO.L vs. GGRP.L
WBIO.L (WisdomTree BioRevolution UCITS ETF USD Acc) and GGRP.L (WisdomTree Global Quality Dividend Growth UCITS ETF - USD) are both exchange-traded funds - WBIO.L is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology TR USD, while GGRP.L is a Global Equities fund tracking the WisdomTree Global Developed Quality Dividend Growth. Both are passively managed. Over the past 3 years, WBIO.L returned 1.10%/yr vs 9.50%/yr for GGRP.L. A 0.60 correlation means they provide meaningful diversification when combined. WBIO.L charges 0.45%/yr vs 0.38%/yr for GGRP.L.
Performance
WBIO.L vs. GGRP.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WBIO.L achieves a 10.42% return, which is significantly higher than GGRP.L's 4.80% return.
WBIO.L
- 1D
- 4.36%
- 1M
- 3.58%
- YTD
- 10.42%
- 6M
- 10.85%
- 1Y
- 51.43%
- 3Y*
- 1.10%
- 5Y*
- —
- 10Y*
- —
GGRP.L
- 1D
- 0.39%
- 1M
- 3.00%
- YTD
- 4.80%
- 6M
- 5.09%
- 1Y
- 16.45%
- 3Y*
- 9.50%
- 5Y*
- 8.60%
- 10Y*
- —
WBIO.L vs. GGRP.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
WBIO.L WisdomTree BioRevolution UCITS ETF USD Acc | 10.42% | 13.58% | -14.08% | -5.86% | -18.74% | -1.39% |
GGRP.L WisdomTree Global Quality Dividend Growth UCITS ETF - USD | 4.80% | 7.06% | 9.85% | 11.62% | -3.21% | 0.34% |
Correlation
The correlation between WBIO.L and GGRP.L is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.50 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.56 |
Correlation (All Time) Calculated using the full available price history since Dec 10, 2021 | 0.60 |
The correlation between WBIO.L and GGRP.L shifts across timeframes, from 0.50 (1 year) to 0.60 (all time), reflecting how their relationship changes across market environments.
WBIO.L vs. GGRP.L - Sectors Allocation Comparison
Sectors
WBIO.L
GGRP.L
Healthcare
Basic Materials
Consumer Defensive
Communication Services
-
Consumer Cyclical
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
WBIO.L
GGRP.L
Basic Materials
WBIO.L
GGRP.L
Consumer Defensive
WBIO.L
GGRP.L
Communication Services
WBIO.L
-
GGRP.L
Consumer Cyclical
WBIO.L
-
GGRP.L
Energy
WBIO.L
-
GGRP.L
Financial Services
WBIO.L
-
GGRP.L
Industrials
WBIO.L
-
GGRP.L
Real Estate
WBIO.L
-
GGRP.L
Technology
WBIO.L
-
GGRP.L
Utilities
WBIO.L
-
GGRP.L
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WBIO.L vs. GGRP.L — Risk / Return Rank
WBIO.L
GGRP.L
WBIO.L vs. GGRP.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) and WisdomTree Global Quality Dividend Growth UCITS ETF - USD (GGRP.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WBIO.L | GGRP.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.31 | ||
| Sortino ratioReturn per unit of downside risk | +0.25 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.30 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 4.40 | 1.89 | +2.51 |
| Martin ratioReturn relative to average drawdown | 10.38 | 7.20 | +3.18 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WBIO.L | GGRP.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.91 | 1.60 | +0.31 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.72 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.19 | 0.90 | -1.09 |
Drawdowns
WBIO.L vs. GGRP.L - Drawdown Comparison
The maximum WBIO.L drawdown since its inception was -51.13%, which is greater than GGRP.L's maximum drawdown of -22.60%. Use the drawdown chart below to compare losses from any high point for WBIO.L and GGRP.L.
Loading charts...
Drawdown Indicators
| WBIO.L | GGRP.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.13% | -22.60% | -28.53% |
Max Drawdown (1Y)Largest decline over 1 year | -11.50% | -8.59% | -2.91% |
Max Drawdown (3Y)Largest decline over 3 years | -39.34% | -16.46% | -22.88% |
Max Drawdown (5Y)Largest decline over 5 years | — | -16.46% | — |
Current DrawdownCurrent decline from peak | -18.76% | 0.00% | -18.76% |
Average DrawdownAverage peak-to-trough decline | -26.35% | -2.93% | -23.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.89% | 2.26% | +2.63% |
Volatility
WBIO.L vs. GGRP.L - Volatility Comparison
WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) has a higher volatility of 6.84% compared to WisdomTree Global Quality Dividend Growth UCITS ETF - USD (GGRP.L) at 3.00%. This indicates that WBIO.L's price experiences larger fluctuations and is considered to be riskier than GGRP.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WBIO.L | GGRP.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.84% | 3.00% | +3.84% |
Volatility (6M)Calculated over the trailing 6-month period | 17.06% | 8.07% | +8.99% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.57% | 10.17% | +16.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.70% | 12.07% | +11.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.70% | 15.35% | +8.35% |
WBIO.L vs. GGRP.L - Expense Ratio Comparison
WBIO.L has a 0.45% expense ratio, which is higher than GGRP.L's 0.38% expense ratio.
Dividends
WBIO.L vs. GGRP.L - Dividend Comparison
WBIO.L has not paid dividends to shareholders, while GGRP.L's dividend yield for the trailing twelve months is around 0.01%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
GGRP.L WisdomTree Global Quality Dividend Growth UCITS ETF - USD | 0.01% | 0.01% | 0.54% | 1.86% | 2.42% | 1.60% | 1.46% | 1.88% | 2.13% | 1.41% |
WBIO.L WisdomTree BioRevolution UCITS ETF USD Acc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
WBIO.L and GGRP.L have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GGRP.L is cheaper at 0.38% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GGRP.L is cheaper with a 0.38% expense ratio, compared with 0.45% for WBIO.L.
WBIO.L is categorized as Health & Biotech Equities, while GGRP.L is Global Equities. WBIO.L tracks NASDAQ Biotechnology TR USD, while GGRP.L tracks WisdomTree Global Developed Quality Dividend Growth. Their fees differ too: 0.45% for WBIO.L and 0.38% for GGRP.L.
Find the right allocation for WBIO.L and GGRP.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer